The Primary Care Companion for CNS Disorders

CME Institute

Home | About Us | Mission Statement | All CME Activities | MyCME | CME Facebook | CME Twitter

JCP

Home | About JCP | Subscribe | Archive | Information for Authors | Information for Reviewers | Information for Advertisers | CNS Job Market | Customer Service | JCP Facebook | JCP Twitter

PCC

Home | About PCC | Register | Archive | Information for Authors | Information for Reviewers | PCC Facebook | PCC Twitter

Help

FAQ | About Psychiatrist.com | Terms of use | Privacy policy

magnifying glass for search

  • magnifying glass for search
  • Advanced Search

Login

Login  
Login | Login Help | Register | Subscribe
Register | Elerts

Quick Links

Font: A | A | A

Top

Purchase PDF

Vol 15, No 1
Table of Contents

Facebook ShareShare

twitter shareTweet This

envelope iconEmail a link

Related ►

Related Articles

[X]

<p class="frontmatter-fieldnotes disclaimernew" style="margin-bottom:15px;">This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s <a href="/pages/termsofuse.aspx" target="_blank">Terms & Conditions</a>.</p> <div id="x12l01443">
<div class="story">
<p class="ltrs-br-ltr-br-title"><span class="bold">Ziprasidone-Induced Ischemic Priapism Requiring Surgical Intervention: A Case Report</span></p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold">To the Editor:</span> This is a case of ischemic priapism necessitating surgical intervention for a patient on ziprasidone treatment.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text"><span class="semibold-ital">Case report.</span> Mr A, a 50-year-old white man with bipolar I disorder (<span class="italic">DSM-IV</span> criteria), had been treated with a combination of ziprasidone and divalproex sodium for the last 6 years. The dose of ziprasidone was 60 mg in the morning and 80 mg at night, which had been his regimen for several years. The patient received advice from his psychiatrist that he should coingest ziprasidone with food to improve the bioavailability. However, the following day (that is, following an ingestion of 80 mg at bedtime and 60 mg in the morning of ziprasidone with food), he presented with a persistent painful penile erection lasting 10 hours.</p>
<p class="ltrs-br-ltr-br-body-text">Mr A was treated with corpora cavernosal drainage and irrigation with phenylephrine injection. Owing to lack of improvement, a proximal Winter shunt with corpora cavernosal drain instillation and a second phenylephrine injection was attempted; however, this was unsuccessful. Spontaneous flaccidity was obtained after 3 days. Urologists recommended balloon pump implantation after 6 to 12 months for ischemia-induced impotence. They concluded ziprasidone as the likely etiology of the ischemic priapism.</p>
<p class="ltrs-br-ltr-br-body-text">The patient had a history of erectile dysfunction treated with as-required sildenafil 100 mg. The last dose was taken 72 hours prior to the onset of priapism. Subsequent to this treatment with sildenafil, the patient had normally functioning erection, ejaculation, and ensuing flaccidity of his penis following sexual activity. Additionally, the patient reported a 2-hour episode of priapism 5 months prior to the current episode, which resolved spontaneously and was unrelated to sildenafil use.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text">Priapism is a urologic emergency, with some patients developing impotence despite medical interventions.<span class="htm-cite"><a href="#ref1">1</a></span> PubMed search with terms <span class="italic">ziprasidone</span> OR <span class="italic">Geodon</span> AND <span class="italic">priapism</span> found only 1 previous report concerning ziprasidone use and ischemic priapism requiring surgical intervention.<span class="htm-cite"><a href="#ref2">2</a></span> Priapism, though uncommon, is referenced as a possible side effect with ziprasidone.</p>
<p class="ltrs-br-ltr-br-body-text">Ziprasidone has an antagonist action on α<span class="subscript">1</span> receptors,<span class="htm-cite"><a href="#ref3">3</a></span> and this action is ostensibly culpable in priapismic reactions. There can be up to a 2-fold increase in bioavailability when ziprasidone is ingested with food, and, hence, patients are normally advised to ingest this medication with at least a 500-calorie dietary intake for better absorption.<span class="htm-cite"><a href="#ref4">4</a></span> This patient had a prolonged history of fasted-state ziprasidone administration, which upon correction elicited a rapid dose-dependent α<span class="subscript">1</span>-mediated ischemic-priapismic reaction to amplified drug concentrations, mandating emergent surgical interventions.</p>
<p class="ltrs-br-ltr-br-body-text">Phosphodiesterase inhibitors, too, can cause prolonged erection<span class="htm-cite"><a href="#ref5">5</a></span>; in this patient’s case, sildenafil is unlikely to have been the cause for 2 primary reasons. Firstly, sildenafil has a short half-life of 3 to 4 hours,<span class="htm-cite"><a href="#ref6">6</a></span> and the duration between sildenafil use and priapism onset was 72 hours. Secondly, there was a return to normal flaccidity following the sexual act when sildenafil was last used. Up to 50% of patients with priapism have a history of prolonged erection.<span class="htm-cite"><a href="#ref7">7</a></span> In this case, an episode of self-resolving prolonged erection was followed by ischemic priapism 5 months later.</p>
<p class="ltrs-br-ltr-br-body-text">We recommend that clinicians educate patients and monitor for sexual side effects not only following initiation and dose increments of ziprasidone, but also during any conditions that promote bioavailability. From this case, we suggest close follow-up or medication switching in those patients who experienced an episode of self-resolving priapism on ziprasidone treatment to prevent adverse reactions such as ischemic priapism and its associated morbidities.</p>
<p class="ltrs-br-ltr-br-references-head"><span class="smallcaps">References</span></p>
<p class="references-references-text-1-9"><a name="ref1"></a>1. Sood S, James W, Bailon MJ. Priapism associated with atypical antipsychotic medications: a review. <span class="italic">Int Clin Psychopharmacol</span>. 2008;23(1):9–17. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18090503&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1097/YIC.0b013e3282f1c1ef">doi:10.1097/YIC.0b013e3282f1c1ef</a></span></p>
<p class="references-references-text-1-9"><a name="ref2"></a>2. Kaufman KR, Stern L, Mohebati A, et al. Ziprasidone-induced priapism requiring surgical treatment. <span class="italic">Eur Psychiatry</span>. 2006;21(1):48–50. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16356688&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1016/j.eurpsy.2005.07.007">doi:10.1016/j.eurpsy.2005.07.007</a></span></p>
<p class="references-references-text-1-9"><a name="ref3"></a>3. Andersohn F, Schmedt N, Weinmann S, et al. Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. <span class="italic">J&nbsp;Clin Psychopharmacol</span>. 2010;30(1):68–71. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20075651&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1097/JCP.0b013e3181c8273d">doi:10.1097/JCP.0b013e3181c8273d</a></span></p>
<p class="references-references-text-1-9"><a name="ref4"></a>4. Lincoln J, Stewart ME, Preskorn SH. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone. <span class="italic">J&nbsp;Psychiatr Pract</span>. 2010;16(2):103–114. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20511734&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1097/01.pra.0000369971.64908.dc">doi:10.1097/01.pra.0000369971.64908.dc</a></span></p>
<p class="references-references-text-1-9"><a name="ref5"></a>5. Aoyagi T, Hayakawa K, Miyaji K, et al. Sildenafil induced priapism. <span class="italic">Bull Tokyo Dent Coll</span>. 1999;40(4):215–217. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11933312&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.2209/tdcpublication.40.215">doi:10.2209/tdcpublication.40.215</a></span></p>
<p class="references-references-text-1-9"><a name="ref6"></a>6. Nichols DJ, Muirhead GJ, Harness JA. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. <span class="italic">Br J Clin Pharmacol</span>. 2002;53(suppl 1):5S–12S. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11879254&dopt=Abstract">PubMed</a> <a href="http://dx.doi.org/10.1046/j.0306-5251.2001.00027.x">doi:10.1046/j.0306-5251.2001.00027.x</a></span></p>
<p class="references-references-text-1-9"><a name="ref7"></a>7. Thompson JW Jr, Ware MR, Blashfield RK. Psychotropic medication and priapism: a comprehensive review. <span class="italic">J&nbsp;Clin Psychiatry</span>. 1990;51(10):430–433. <span class="pubmed-crossref"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2211542&dopt=Abstract">PubMed</a></span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Kevin Denton, BS</span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Venkata Kolli, MBBS, MRCPsych</span></p>
<p class="ltrs-br-ltr-br-author"><a href="mailto:kollivb@gmail.com">kollivb@gmail.com</a></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Ashish Sharma, MD</span></p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Author affiliations:</span> University of Nebraska Medical Center (Mr Denton); Psychiatry Residency Program, Creighton-Nebraska (Dr Kolli); and University of Nebraska College of Medicine (Dr Sharma), Omaha.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Potential conflicts of interest:</span> None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Funding/support:</span> None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="semibold-ital">Published online:</span><span class="italic"> February 14, 2013.</span></p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">Prim Care Companion CNS Disord 2013;15(1):</span><span class="doi">doi:10.4088/PCC.12l01443</span></p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">© Copyright 2013 Physicians Postgraduate Press, Inc.</span></p>
</div>
</div>
Manage Subscriptions
/_layouts/images/ReportServer/Manage_Subscription.gif
/PCC/article/_layouts/ReportServer/ManageSubscriptions.aspx?list={ListId}&ID={ItemId}
0x80
0x0
FileType
rdl
350
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
351
Manage Shared Datasets
/PCC/article/_layouts/ReportServer/DatasetList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
352
Manage Parameters
/PCC/article/_layouts/ReportServer/ParameterList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
353
Manage Processing Options
/PCC/article/_layouts/ReportServer/ReportExecution.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
354
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
355
View Report History
/PCC/article/_layouts/ReportServer/ReportHistory.aspx?list={ListId}&ID={ItemId}
0x0
0x40
FileType
rdl
356
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
350
Edit Data Source Definition
/PCC/article/_layouts/ReportServer/SharedDataSource.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
351
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
350
Manage Clickthrough Reports
/PCC/article/_layouts/ReportServer/ModelClickThrough.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
352
Manage Model Item Security
/PCC/article/_layouts/ReportServer/ModelItemSecurity.aspx?list={ListId}&ID={ItemId}
0x0
0x2000000
FileType
smdl
353
Regenerate Model
/PCC/article/_layouts/ReportServer/GenerateModel.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
354
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
smdl
351
Load in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderModelContext&list={ListId}&ID={ItemId}
0x0
0x2
FileType
smdl
250
Edit in Report Builder
/_layouts/images/ReportServer/EditReport.gif
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderReportContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
250
Edit in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderDatasetContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
250
Manage Caching Options
/PCC/article/_layouts/ReportServer/DatasetCachingOptions.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
350
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}&IsDataset=true
0x0
0x4
FileType
rsd
351
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rsd
352
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
353
Compliance Details
javascript:commonShowModalDialog('{SiteUrl}/_layouts/itemexpiration.aspx?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/hold.aspx?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/Reporting.aspx?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/expirationconfig.aspx?ID={ItemId}&List={ListId}'); return false;}}, null); return false;
0x0
0x1
ContentType
0x01
898
Document Set Version History
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}/_layouts/DocSetVersions.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
javascript:GoToPage('{SiteUrl}/_layouts/docsetsend.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350

Information Links

Terms of Use | Privacy Policy | Information for Authors (JCP) | Information for Authors (PCC) | Reprints and Permissions | CNS Job Market | Information for Advertisers | Media Relations | PPP COVID-19 Statement

Help

Contact us | Unsubscribe from Elerts | Customer Service | FAQ | About JCP | About PCC | About Psychiatrist.com

Our Family of Sites

Psychiatrist.com | The Journal of Clinical Psychiatry | The Primary Care Companion | The CME Institute | Strong Veterans
Anonymous